Prolactin and Autoimmunity

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2018 Feb 28

PMID 29483903

Citations 77

Authors

Vania Vieira Borba

Gisele Zandman-Goddard

Yehuda Shoenfeld

Affiliations

Soon will be listed here.

Abstract

The great asymmetry of autoimmune diseases between genders represents one of the most enigmatic observations among the mosaic of autoimmunity. Sex hormones are believed to play a crucial role on this dimorphism. The higher prevalence of autoimmunity among women at childbearing ages, disease onset/relapses during pregnancy, and post-partum are some of the arguments that support this hypothesis. Certainly, motherhood represents one of the most remarkable challenges for the immune system, which not only has to allow for the conceptus, but also has to deal with complex endocrine alterations. Hormonal homeostasis is known to exert a crucial influence in achieving a competent and healthy immune system. Prolactin (PRL) has a bioactive function acting as a hormone and a cytokine. It interferes with immune system modulation, mainly inhibiting the negative selection of autoreactive B lymphocytes. Likewise, hyperprolactinemia has been described in relation to the pathogenesis and activity of several autoimmune disorders. Dopamine is an effective inhibitor of PRL secretion due to either a direct influence on the hypophysis or stimulation of postsynaptic dopamine receptors in the hypothalamus, arousing the release of the PRL inhibitory factor. Hence, dopamine agonists have proven to offer clinical benefits among autoimmune patients and represent a promising therapy to be explored. In this review, we attempt to provide a critical overview of the link between PRL, autoimmune diseases, and motherhood.

Citing Articles

Association of Genes , and with Milk Performance, Reproductive Traits and Heat Stress Response in Dairy Cattle.

Fang Q, Zhang H, Gao Q, Hu L, Zhang F, Xu Q Int J Mol Sci. 2025; 26(5).

PMID: 40076589 PMC: 11901056. DOI: 10.3390/ijms26051963.

Identification of tacrolimus-related genes in familial combined hyperlipidemia and development of a diagnostic model using bioinformatics analysis.

Xu Y, He H, Li H Heliyon. 2025; 11(3):e41705.

PMID: 39916852 PMC: 11800081. DOI: 10.1016/j.heliyon.2025.e41705.

The Influence of Concurrent Autoimmune Thyroiditis on the Cardiometabolic Consequences of Cabergoline in Postmenopausal Women.

Krysiak R, Basiak M, Szkrobka W, Okopien B Metabolites. 2025; 15(1).

PMID: 39852352 PMC: 11767027. DOI: 10.3390/metabo15010009.

Re-embarking in ART while still breastfeeding: an unresolved question.

Dallagiovanna C, Di Stefano G, Reschini M, Invernici D, Comana S, Somigliana E Arch Gynecol Obstet. 2025; 311(2):555-565.

PMID: 39828777 PMC: 11890365. DOI: 10.1007/s00404-025-07933-8.

Elevated levels of exogenous prolactin promote inflammation at the maternal-fetal interface via the JAK2/STAT5B signaling axis.

Williams A, Hossack D, Thompson N, Sim Y, Wilson C, Schuch V Front Immunol. 2025; 15:1496610.

PMID: 39763651 PMC: 11701216. DOI: 10.3389/fimmu.2024.1496610.

References

De Bellis A, Colao A, Pivonello R, Savoia A, Battaglia M, Ruocco G . Antipituitary antibodies in idiopathic hyperprolactinemic patients. Ann N Y Acad Sci. 2007; 1107:129-35. DOI: 10.1196/annals.1381.014. View

Marcotegui A, Garcia-Calvo A . [Biochemical diagnosis of monomeric hyperprolactinemia]. An Sist Sanit Navar. 2011; 34(2):145-52. DOI: 10.4321/s1137-66272011000200002. View

Buckley A . Prolactin, a lymphocyte growth and survival factor. Lupus. 2001; 10(10):684-90. DOI: 10.1191/096120301717164912. View

Hellwig K, Rockhoff M, Herbstritt S, Borisow N, Haghikia A, Elias-Hamp B . Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses. JAMA Neurol. 2015; 72(10):1132-8. DOI: 10.1001/jamaneurol.2015.1806. View

Tan I, Peeva E, Zandman-Goddard G . Hormonal modulation of the immune system - A spotlight on the role of progestogens. Autoimmun Rev. 2015; 14(6):536-42. DOI: 10.1016/j.autrev.2015.02.004. View

Haghikia A, Kaya Z, Schwab J, Westenfeld R, Ehlermann P, Bachelier K . Evidence of autoantibodies against cardiac troponin I and sarcomeric myosin in peripartum cardiomyopathy. Basic Res Cardiol. 2015; 110(6):60. DOI: 10.1007/s00395-015-0517-2. View

Sundstrom J, Fett J, Carraway R, Ansari A . Is peripartum cardiomyopathy an organ-specific autoimmune disease?. Autoimmun Rev. 2003; 1(1-2):73-7. DOI: 10.1016/s1568-9972(01)00009-x. View

Zandman-Goddard G, Peeva E, Shoenfeld Y . Gender and autoimmunity. Autoimmun Rev. 2007; 6(6):366-72. DOI: 10.1016/j.autrev.2006.10.001. View

Belbasis L, Bellou V, Evangelou E, Ioannidis J, Tzoulaki I . Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol. 2015; 14(3):263-73. DOI: 10.1016/S1474-4422(14)70267-4. View

10.

Tincani A, DallAra F, Lazzaroni M, Reggia R, Andreoli L . Pregnancy in patients with autoimmune disease: A reality in 2016. Autoimmun Rev. 2016; 15(10):975-7. DOI: 10.1016/j.autrev.2016.07.017. View

11.

Costanza M, Binart N, Steinman L, Pedotti R . Prolactin: a versatile regulator of inflammation and autoimmune pathology. Autoimmun Rev. 2014; 14(3):223-30. DOI: 10.1016/j.autrev.2014.11.005. View

12.

Majumdar A, Mangal N . Hyperprolactinemia. J Hum Reprod Sci. 2013; 6(3):168-75. PMC: 3853872. DOI: 10.4103/0974-1208.121400. View

13.

Stuebe A, Meltzer-Brody S, Pearson B, Pedersen C, Grewen K . Maternal neuroendocrine serum levels in exclusively breastfeeding mothers. Breastfeed Med. 2015; 10(4):197-202. PMC: 4410437. DOI: 10.1089/bfm.2014.0164. View

14.

Leanos-Miranda A, Cardenas-Mondragon G, Ulloa-Aguirre A, Isordia-Salas I, Parra A, Ramirez-Peredo J . Anti-prolactin autoantibodies in pregnant women with systemic lupus erythematosus: maternal and fetal outcome. Lupus. 2007; 16(5):342-9. DOI: 10.1177/0961203307078197. View

15.

Parra-Medina R, Molano-Gonzalez N, Rojas-Villarraga A, Agmon-Levin N, Arango M, Shoenfeld Y . Prevalence of celiac disease in latin america: a systematic review and meta-regression. PLoS One. 2015; 10(5):e0124040. PMC: 4420463. DOI: 10.1371/journal.pone.0124040. View

16.

Tang C, Li Y, Lin X, Ye J, Li W, He Z . Prolactin increases tumor necrosis factor alpha expression in peripheral CD14 monocytes of patients with rheumatoid arthritis. Cell Immunol. 2014; 290(1):164-8. DOI: 10.1016/j.cellimm.2014.06.005. View

17.

Yang X, Liang L, Xu H, He M, Yao S, Zhan Z . [Efficacy of oral bromocriptine in protecting the postpartum systemic lupus erythematosus patients from disease relapse]. Zhonghua Nei Ke Za Zhi. 2003; 42(9):621-4. View

18.

Jara L, Benitez G, Medina G . Prolactin, dendritic cells, and systemic lupus erythematosus. Autoimmun Rev. 2008; 7(3):251-5. DOI: 10.1016/j.autrev.2007.11.018. View

19.

Matera L, Galetto A, Geuna M, Vekemans K, Ricotti E, Contarini M . Individual and combined effect of granulocyte-macrophage colony-stimulating factor and prolactin on maturation of dendritic cells from blood monocytes under serum-free conditions. Immunology. 2000; 100(1):29-36. PMC: 2326992. DOI: 10.1046/j.1365-2567.2000.00996.x. View

20.

Anaya J, Shoenfeld Y, Cervera R . Systemic lupus erythematosus 2014. Autoimmune Dis. 2014; 2014:274323. PMC: 3982263. DOI: 10.1155/2014/274323. View